ALENDRONATE-CONTAINING ORAL LIQUID COMPOSITIONS Russian patent published in 2001 - IPC

Abstract RU 2176507 C2

FIELD: medicine, pharmacy. SUBSTANCE: invention relates to method of treatment and prophylaxis of bone thinning in patients by administration of alendronate liquid composition that can be swallowed easily. Invention describes also pharmaceutical dosed forms of alendronate as syrup, an aqueous solution or solution prepared by power dissolving to realize the therapeutical method described. These compositions can be administrated in patients having difficulty in swallowing. EFFECT: improved medicinal form and stability of drug. 25 cl, 3 ex

Similar patents RU2176507C2

Title Year Author Number
BIPHOSPHONATE APPLICATION FOR INHIBITING BONE RESORPTION ARISING AS A RESULT OF ORTHOPEDIC PROSTHESIS IMPLANTATION 1995
  • Ehshli Dzh. Ehjts
RU2161032C2
FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS 2003
  • Mejssner Robert S.
  • Perkins Dzhejms Dzh.
RU2320670C2
DRUG TRANSPORT MEANS AND METHOD OF PREPARATION THEREOF 1992
  • Dzheral'D S.Rork
  • Dzhejms D.Pipkin
RU2127586C1
METHOD OF TREATMENT OF ANDROGEN ALOPECIA WITH 5-ALPHA-REDUCTASE INHIBITORS 1994
  • Glenn Dzh. Gomli
  • Kejt D. Kaufman
  • Ehlizabet Stoner
  • Dzhoann Val'Dshtrajkher
RU2173152C2
METHOD OF MAKING TABLET CONTAINING BISPHOSPHONIC ACIDS, SOLID MEDICINAL FORM AND PHARMACEUTICAL COMPOSITION 1993
  • Bechard Sajmon R.
  • Kramer Kennet A.
  • Kehtdehjr Ashok V.
RU2148405C1
COMBINATION OF INHIBITORS OF HIV-PROTEASE 1995
  • Dojch Pol Dzh.
  • Ehmini Ehmilio A.
  • Vehkka Dzhozef P.
RU2194506C2
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
METHOD OF PREPARING PHENYL HETEROCYCLES, AND INTERMEDIATE COMPOUND 1995
  • Richard Dezmond
  • Ul'F Dolling
  • Ben Mehrk'Jun
  • Richard Tillajer
  • Dehvid Chehn
RU2160257C2
BENZOXAZINONES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF FOR INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, TREATMENT AND PROPHYLAXIS OF AIDS AND ARS, METHOD OF INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, METHOD OF PROPHYLAXIS OF HIV INFECTION, TREATMENT OF HIV AND ARS, COMBINATIONS, METHOD OF SYNTHESIS OF (-)-6-CHLORO- -4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4- -DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE 1993
  • Jang Stiven D.
  • Britcher Sjuzn F.
  • Pejn Linda S.
  • Tran Likkhan O.
  • Lamma Vill'Jam K. Ml.
RU2186775C2
N-(2-BENZYL)-2-PHENYLBUTANAMIDES AS ANDROGEN RECEPTOR MODULATORS 2005
  • Khanni Barbara
  • Kim Juntae
  • Krout Majkl R.
  • Mejssner Robert S.
  • Mitchell Khelen Dzh.
  • Masselman Dzheffri
  • Perkins Dzhejms Dzh.
  • Vang Dziabing
RU2378255C2

RU 2 176 507 C2

Authors

Brenner Dzherald S.

Kehtdehjr Ehshok V.

Pretser Deniz

Uajtford Donna T.

Dates

2001-12-10Published

1995-05-12Filed